Julia Blievernicht
- Pharmacology top 0.5%
- Oncology top 5%
- Infectious Diseases top 5%
- Molecular Biology
- Virology top 5%
- Co-authors
- Ulrich M. ZangerKathrin KleinMatthias SchwabTanja SaußeleElke SchaeffelerMichel EichelbaumMarco H. HofmannDavid A. Flockhart
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Drug Transport and Resistance Mechanisms (6 papers)HIV/AIDS drug development and treatment (4 papers)
- Journals
- Journal of Clinical OncologyJournal of Pharmacology and Experimental TherapeuticsClinical Chemistry
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Julia Blievernicht
10 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 79
- Pharmacology 593
- Oncology 510
- Infectious Diseases 365
- Molecular Biology 230
- Virology 212
Countries citing papers authored by Julia Blievernicht
This map shows the geographic impact of Julia Blievernicht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Blievernicht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Blievernicht more than expected).
Fields of papers citing papers by Julia Blievernicht
This network shows the impact of papers produced by Julia Blievernicht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Blievernicht. The network helps show where Julia Blievernicht may publish in the future.
Co-authorship network of co-authors of Julia Blievernicht
This figure shows the co-authorship network connecting the top 25 collaborators of Julia Blievernicht. A scholar is included among the top collaborators of Julia Blievernicht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Blievernicht. Julia Blievernicht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 172 | |
| 3 | 288 | |
| 4 | 208 | |
| 5 | 50 | |
| 6 | 196 | |
| 7 | 183 | |
| 8 | 84 | |
| 9 | 73 | |
| 10 | 29 |
About Julia Blievernicht
Julia Blievernicht is a scholar working on Pharmacology, Oncology and Infectious Diseases, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Pharmacology (593 citations), Virology (212 citations) and Infectious Diseases (365 citations). Julia Blievernicht has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ulrich M. Zanger, Kathrin Klein, Matthias Schwab, Tanja Saußele, Elke Schaeffeler, Michel Eichelbaum, Marco H. Hofmann, David A. Flockhart, Jürgen Dippon and Claudia Marx. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.